VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 122 filers reported holding VERVE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $346 | -44.6% | 26,097 | -21.8% | 0.00% | -50.0% |
| Q2 2023 | $625 | +28.1% | 33,351 | -1.5% | 0.01% | +50.0% |
| Q1 2023 | $488 | -3.4% | 33,876 | +29.8% | 0.00% | 0.0% |
| Q4 2022 | $505 | -99.9% | 26,097 | 0.0% | 0.00% | -63.6% |
| Q3 2022 | $896,000 | +124.6% | 26,097 | 0.0% | 0.01% | +175.0% |
| Q2 2022 | $399,000 | +92.8% | 26,097 | +187.6% | 0.00% | +100.0% |
| Q1 2022 | $207,000 | – | 9,073 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alphabet Inc. | 10,974,011 | $515,778,000 | 12.24% |
| Casdin Capital, LLC | 3,038,167 | $142,794,000 | 3.55% |
| Redmile Group, LLC | 1,869,030 | $87,844,000 | 1.53% |
| Logos Global Management LP | 443,265 | $20,833,000 | 1.50% |
| Novo Holdings A/S | 600,000 | $28,200,000 | 1.46% |
| Cormorant Asset Management, LP | 709,224 | $32,667,000 | 1.33% |
| Rock Springs Capital Management LP | 962,826 | $45,253,000 | 0.95% |
| HighVista Strategies LLC | 18,782 | $883,000 | 0.58% |
| RA Capital Management | 880,284 | $41,373,000 | 0.57% |
| Nicholas Investment Partners, LP | 132,300 | $6,218,000 | 0.45% |